Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 28,752 shares at $0.49 ($14K) on 2022-05-03, disclosed to the SEC on 2022-05-05.
Scheduled sale ($14k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |